Trial Profile
A Pilot Study of Combined Modality Therapy for Recurrent Head and Neck Carcinoma
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 31 Mar 2023
Price :
$35
*
At a glance
- Drugs Amifostine (Primary) ; Cisplatin (Primary) ; Fluorouracil (Primary)
- Indications Head and neck cancer; Squamous cell cancer
- Focus Therapeutic Use
- 11 Jan 2022 Status changed from completed to discontinued.
- 15 Apr 2020 Status changed from active, no longer recruiting to completed.
- 26 Oct 2009 New trial record